These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 36099786)

  • 21. Metformin Is Associated With Improved Inflammatory Bowel Disease Outcomes in Patients With Type 2 Diabetes Mellitus: A Propensity-Matched Cohort Study.
    Petrov JC; Desai AA; Kochhar GS; Crosby SK; Kinnucan JA; Picco MF; Hashash JG; Farraye FA
    Inflamm Bowel Dis; 2024 Jul; ():. PubMed ID: 39001616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunomodulatory Effects of Flavonoids in the Prophylaxis and Treatment of Inflammatory Bowel Diseases: A Comprehensive Review.
    Ribeiro D; Proenca C; Rocha S; Lima JLFC; Carvalho F; Fernandes E; Freitas M
    Curr Med Chem; 2018; 25(28):3374-3412. PubMed ID: 29446723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IBD immunopathogenesis: A comprehensive review of inflammatory molecules.
    Park JH; Peyrin-Biroulet L; Eisenhut M; Shin JI
    Autoimmun Rev; 2017 Apr; 16(4):416-426. PubMed ID: 28212924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological Treatments.
    de Mattos BR; Garcia MP; Nogueira JB; Paiatto LN; Albuquerque CG; Souza CL; Fernandes LG; Tamashiro WM; Simioni PU
    Mediators Inflamm; 2015; 2015():493012. PubMed ID: 26339135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Regulation of inflammatory bowel disease by amino acids].
    Sun Q; Wu H; Li S; Sun Z
    Sheng Wu Gong Cheng Xue Bao; 2022 Jun; 38(6):2128-2138. PubMed ID: 35786467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paediatric Inflammatory Bowel Disease and its Relationship with the Microbiome.
    Fitzgerald RS; Sanderson IR; Claesson MJ
    Microb Ecol; 2021 Nov; 82(4):833-844. PubMed ID: 33666710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current scenario in inflammatory bowel disease: drug development prospects.
    Chandel S; Prakash A; Medhi B
    Pharmacol Rep; 2015 Apr; 67(2):224-9. PubMed ID: 25712643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural products targeting Nrf2/ARE signaling pathway in the treatment of inflammatory bowel disease.
    Li B; Wang Y; Jiang X; Du H; Shi Y; Xiu M; Liu Y; He J
    Biomed Pharmacother; 2023 Aug; 164():114950. PubMed ID: 37263167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dimethyl Fumarate and Intestine: From Main Suspect to Potential Ally against Gut Disorders.
    Manai F; Zanoletti L; Arfini D; Micco SG; Gjyzeli A; Comincini S; Amadio M
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring the Phosphatidylcholine in Inflammatory Bowel Disease: Potential Mechanisms and Therapeutic Interventions.
    Ai R; Xu J; Ji G; Cui B
    Curr Pharm Des; 2022; 28(43):3486-3491. PubMed ID: 36424797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin ameliorates chronic colitis in a mouse model by regulating interferon-γ-producing lamina propria CD4
    Takahara M; Takaki A; Hiraoka S; Takei K; Yasutomi E; Igawa S; Yamamoto S; Oka S; Ohmori M; Yamasaki Y; Inokuchi T; Kinugasa H; Harada K; Udono H; Okada H
    FASEB J; 2022 Feb; 36(2):e22139. PubMed ID: 35064693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Inflammatory bowel diseases (IBD) -- critical discussion of etiology, pathogenesis, diagnostics, and therapy].
    Ochsenkühn T; Sackmann M; Göke B
    Radiologe; 2003 Jan; 43(1):1-8. PubMed ID: 12552369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic Potential of Amino Acids in Inflammatory Bowel Disease.
    Liu Y; Wang X; Hu CA
    Nutrients; 2017 Aug; 9(9):. PubMed ID: 28832517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral locally active steroids in inflammatory bowel disease.
    Nunes T; Barreiro-de Acosta M; Marin-Jiménez I; Nos P; Sans M
    J Crohns Colitis; 2013 Apr; 7(3):183-91. PubMed ID: 22784947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early discontinuation of biological therapy among inflammatory bowel disease patients in Bahrain: Real world experience.
    Abdulla M; AlQamish J; Mohammed N; Al Saeed M; Al Aali HJ; Al Khaja A; Hasan ZAIY; Haider FY; Ebrahim SDN; Mahfoodh ZSA; Hubail MAH; Alhajri I; Al-Matrook F; Tork A
    Saudi J Gastroenterol; 2022; 28(3):193-200. PubMed ID: 35083972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The rationale for selenium supplementation in inflammatory bowel disease: A mechanism-based point of view.
    Ala M; Kheyri Z
    Nutrition; 2021 May; 85():111153. PubMed ID: 33578241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current, New and Future Therapeutic Targets in Inflammatory Bowel Disease: A Systematic Review.
    Alimohammadi N; Koosha F; Rafeian-Kopaei M
    Curr Pharm Des; 2020; 26(22):2668-2675. PubMed ID: 32250220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Review on the Use of Anti-TNF in Children and Adolescents with Inflammatory Bowel Disease.
    Aardoom MA; Veereman G; de Ridder L
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31126015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The therapeutic potential of carbon monoxide for inflammatory bowel disease.
    Takagi T; Uchiyama K; Naito Y
    Digestion; 2015; 91(1):13-8. PubMed ID: 25632911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.